Beyond Sendai Virus: A New High-Efficiency Approach to PBMC iPSC Reprogramming

Join uBriGene and Emory Stem Cell and Organoids Core (ESCOC) for a webinar on next-generation iPSC reprogramming technologies and PBMC reprogramming workflows.

The webinar will provide deeper technical insights into the uBriGene’s non-viral RNA–LNP iPSC reprogramming platform, including circRNA-based reprogramming factors, GMP iPSC banks, and downstream differentiation applications for regenerative medicine and cell therapy.

Adriana from Emory Stem and Organoid Core will discuss the recently published study comparing uBriGene's RNA-LNP reprogramming cocktail with the Sendai virus method. The webinar will provide technical insights into the experimental design, key findings, and practical considerations for PBMC-to-iPSC reprogramming.

Key Discussion Topics

Whether you are developing new approach methodologies (NAM) disease models, regenerative medicine programs, or iPSC-enabled cell therapies, this webinar will provide valuable scientific and practical insights into next-generation iPSC reprogramming technologies.

GMP Circular RNA LNP: Process Development and Manufacturing Innovations for the Next Frontier of ATMPs

Circular RNA (circRNA) is an emerging RNA modality within the advanced therapy medicinal product (#ATMP) landscape, offering the potential for durable protein expression, enhanced stability, and reduced immunogenicity and toxicity compared with linear mRNA. CircRNA therapeutics may also enable fewer dosing requirements, cost-efficient enzyme-free downstream processing, and a potentially faster path toward clinical development following IND clearance.

Despite these advantages, developing and manufacturing circRNA–LNP therapeutics presents unique challenges, including achieving high circularization efficiency and purity, optimizing LNP formulation, and demonstrating sustained in vivo expression through fit-for-purpose analytical methods.

In this joint webinar, uBriGene Biosciences and Circurna will present complementary capabilities to support circRNA programs from discovery to clinical translation. uBriGene will highlight process development, scalable GMP manufacturing, and analytical strategies addressing key CMC challenges, while Circurna will introduce its ciRNA™ platform, including circular RNA design, payload optimization, and delivery approaches.

The session will also share practical insights into circRNA purification, circRNA-LNP formulation, and emerging trends shaping the future of circRNA therapeutics.

High Efficiency iPSC Reprogramming for Regenerative Medicine: RNA LNP complete kits

uBriGene Biosciences delivers high efficiency total solution designed to accelerate the development of iPSC-derived cell therapies.

In this webinar, you’ll discover uBriGene’s expanding portfolio of iPSC innovations, including:

Join us to see how uBriGene’s solutions can accelerate the development of iPSC-based therapeutics, advancing the next generation of cell therapies and disease models.